FDA to Evaluate BLAs for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
February 19th 2021Two supplemental BLAs have been submitted to the FDA for enfortumab vedotin-ejfv to convert its accelerated approval into a regular one and to expand the current label to include patients with locally advanced or metastatic urothelial cancer.
Read More
Study Tests Whether Pub Operators Can Effectively, Consistently Prevent COVID-19 Transmission
February 18th 2021The research team conducted interviews with stakeholders to gauge the sector’s thoughts around implementing COVID-19 measures in licensed premises prior to COVID-19 restrictions being lifted.
Read More
Study Finds Medical Debt Can Result in Significant Adverse Effects on Physical, Mental Health
February 18th 2021Communication plays a critical role in coping strategies around health and financial challenges, according to a recent qualitative study that investigated how people cope with these challenges.
Read More
Vicineum Granted FDA Priority Review for Non–Muscle Invasive Bladder Cancer
February 18th 2021The FDA granted a priority review designation to the biologics license application for Vicineum for use in patients with high-risk Bacillus Calmette-Guérin–unresponsive non–muscle invasive bladder cancer.
Read More
Moderna Provides Update on US COVID-19 Vaccine Supply
February 17th 2021To date, 45.4 million doses of Moderna’s COVID-19 vaccine have been supplied to the US government, according to a recent update from the company that details progress on their ongoing collaboration with the US government.
Read More
Study: High Rate of Smoking Reduction, Cessation in Patients With Lung Cancer Following Study Entry
February 17th 2021A recent comprehensive, prospective study of smoking habits among patients with non-small cell lung cancer demonstrated a high rate of smoking reduction and cessation following entry into the phase 3 early-stage trial.
Read More
Study: Anti-Obesity Medication Twice as Effective as Most Weight Loss Drugs
February 16th 2021One-third of study participants treated with semaglutide lost at least 20% (46 pounds) of their baseline weight, which is a common reduction for many patients who have had bariatric surgery in the 1 to 3 years following their procedure.
Read More
COVID-19 Pandemic ‘Unveiled’ Preexisting Racial Disparities in Health Care
February 15th 2021In a discussion regarding racial disparities and impediments to getting more people of color vaccinated, Laurie Zephyrin, MD, MPH, MBA, vice president of the delivery system reform at The Commonwealth Fund, explained some of the key factors.
Read More
Study: Goldenseal Use May Compromise Glucose Control in Diabetics
February 15th 2021The objective of the study was to determine the impact of goldenseal on specific drug transporters, proteins that facilitate absorption or expulsion of drug molecules in different tissues, such as the intestine, liver, and kidney.
Read More